Advisor Group’s Apyx Medical APYX Stock Holding History

Advisor Group’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$4K	Hold	416	–	–	﹤0.01%	4727
2019 Q3	$3K	Sell	416 -105	-20%	-$745	﹤0.01%	4807
2019 Q2	$4K	Buy	+521	New	+$2.83K	﹤0.01%	4733
2018 Q4	–	Sell	-1,000	Closed	-$7K	–	5087
2018 Q3	$7K	Hold	1,000	–	–	﹤0.01%	4435
2018 Q2	$4K	Hold	1,000	–	–	﹤0.01%	4441
2018 Q1	$3K	Sell	1,000 -31,300	-97%	-$80.5K	﹤0.01%	4556
2017 Q4	$84K	Buy	+32,300	New	+$101K	﹤0.01%	2702
2017 Q3	–	Sell	-2,500	Closed	-$6K	–	4826
2017 Q2	$6K	Buy	+2,500	New	+$6.14K	﹤0.01%	4151

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Advisor Group's APYX Position: Q4 2019 in Review

Advisor Group held its Apyx Medical (APYX) position steady in Q4 2019 at 416 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4727.

Advisor Group first reported a position in APYX in Q2 2017 and has held it in 8 quarters since. The position peaked at $84K in Q4 2017. 69 funds tracked by Wall St. Rank hold APYX as of Q4 2019.

Advisor Group held 416 shares of Apyx Medical worth $4K as of Q4 2019.
Advisor Group left its Apyx Medical share count unchanged in Q4 2019.
Apyx Medical made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4727 holding.
Advisor Group first reported a position in Apyx Medical in Q2 2017 and has held it in 8 quarters since.
Advisor Group's Apyx Medical position peaked at $84K in Q4 2017.
69 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.